Febomus 40 Tablet contains Febuxostat 40mg, a medication primarily used to manage hyperuricemia in patients with gout. Febuxostat works by selectively inhibiting xanthine oxidase, an enzyme responsible for converting purines into uric acid, thereby reducing serum uric acid levels. This reduction helps prevent gout attacks and the formation of uric acid crystals in joints and tissues, which cause pain and inflammation. Febomus 40 is typically prescribed for patients who have not responded well to other urate-lowering therapies or who have contraindications to allopurinol. It is important to take this medication exactly as directed by a healthcare professional, usually once daily, with or without food. Patients should maintain adequate hydration while on Febomus to help prevent kidney stones. Common side effects may include nausea, joint pain, rash, or liver function abnormalities, so regular monitoring of liver enzymes is recommended during treatment. Febomus 40 is not suitable for patients with severe liver or kidney impairment and should be used cautiously in those with cardiovascular disease. Always inform your doctor about any other medications you are taking to avoid potential interactions. This medication is intended for long-term management and should be used under medical supervision.